论文部分内容阅读
目的:观察血塞通注射液配合西药治疗脑梗死的临床效果。方法:将102例脑梗死患者随机分成对照组和试验组各51例,两组患者均给予对症治疗,对照组患者采用西药氯吡格雷治疗,试验组患者采用血塞通注射液配合氯吡格雷治疗。观察比较两组患者临床疗效、神经功能缺损评分(NIHSS)、生活质量巴塞尔指数(Barthel)及不良反应发生情况。结果:试验组患者NIHSS分数明显低于对照组,临床疗效、Barthel分数明显优于对照组,差异具有统计学意义(P<0.05);两组患者不良反应发生率无统计学差异(P>0.05)。结论:血塞通注射液配合氯吡格雷治疗脑梗死可改善患者神经功能,提高其生活质量水平,且作用安全,值得临床推广应用。
Objective: To observe the clinical effect of Xuesaitong injection combined with western medicine in treating cerebral infarction. Methods: 102 cases of cerebral infarction were randomly divided into control group and experimental group of 51 cases, both groups were given symptomatic treatment, the control group of patients with Western medicine clopidogrel treatment, the test group patients with Xuesaitong injection combined with clopidogrel treatment. The clinical efficacy, neurological deficit score (NIHSS), quality of life Basel (Barthel) and incidence of adverse reactions were compared between the two groups. Results: The NIHSS score of the experimental group was significantly lower than that of the control group. The clinical curative effect and Barthel score were significantly better than those of the control group (P <0.05). There was no significant difference in adverse reactions between the two groups (P> 0.05 ). Conclusion: Xuesaitong injection combined with clopidogrel in the treatment of cerebral infarction can improve the neurological function, improve the quality of life, and the role of safety, worthy of clinical application.